Research Overview: Anastrozole 1mg Swiss Healthcare
Anastrozole 1mg Swiss Healthcare is a selective aromatase inhibitor widely studied for its potent anti-estrogenic properties in laboratory research. This pharmaceutical-grade compound demonstrates exceptional selectivity for the aromatase enzyme, making it invaluable for researchers investigating hormonal pathway interactions and endocrine system modulation. Scientists studying metabolic processes frequently evaluate anastrozole’s mechanism of action in controlled experimental settings.
Research institutions conducting hormonal studies utilise anastrozole to examine estrogen biosynthesis inhibition and its downstream effects on cellular metabolism. The compound’s specificity for aromatase makes it particularly suitable for investigating how reduced estrogen production influences various physiological pathways. Laboratory analysis has demonstrated anastrozole’s ability to significantly suppress estrogen levels, providing researchers with a reliable tool for hormonal manipulation studies.
Laboratory Research Applications
Researchers at Stroid UK Shop frequently study anastrozole’s interactions with other research compounds. Studies examining post-cycle therapy protocols often investigate how aromatase inhibitors work alongside selective androgen receptor modulators and research peptides. The compound’s mechanism enables scientists to evaluate complex hormonal interactions in vitro.
Laboratory investigations commonly examine anastrozole’s role in estrogen receptor modulation studies. Researchers analyse how aromatase inhibition affects cellular signalling pathways, particularly in hormone-sensitive tissue cultures. The compound’s selective action makes it essential for studies requiring precise control over estrogenic activity in experimental models.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Anastrozole |
| Concentration | 1mg per tablet |
| Manufacturer | Swiss Healthcare |
| Purity | ≥98% (HPLC verified) |
| CAS Number | 120511-73-1 |
| Molecular Formula | C17H19N5 |
| Molecular Weight | 293.37 g/mol |
| Storage Conditions | Cool, dry place |
Research Compliance Statement
This anastrozole product is supplied exclusively for in-vitro research purposes by qualified researchers and institutions. Studies involving aromatase inhibitors must comply with institutional research protocols and regulatory guidelines. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments.
